Citation Formats
In vitro cytotoxic effect of PARP inhibitor alone and in combination with nab-paclitaxel on triple-negative and luminal A breast cancer cells
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

M. R. Topcul Et Al. , "In vitro cytotoxic effect of PARP inhibitor alone and in combination with nab-paclitaxel on triple-negative and luminal A breast cancer cells," ONCOLOGY REPORTS , vol.40, pp.527-535, 2018

Topcul, M. R. Et Al. 2018. In vitro cytotoxic effect of PARP inhibitor alone and in combination with nab-paclitaxel on triple-negative and luminal A breast cancer cells. ONCOLOGY REPORTS , vol.40 , 527-535.

Topcul, M. R., Cetin, I., Turan, S. O., & Ozar, M. O. K., (2018). In vitro cytotoxic effect of PARP inhibitor alone and in combination with nab-paclitaxel on triple-negative and luminal A breast cancer cells. ONCOLOGY REPORTS , vol.40, 527-535.

Topcul, Mehmet Et Al. "In vitro cytotoxic effect of PARP inhibitor alone and in combination with nab-paclitaxel on triple-negative and luminal A breast cancer cells," ONCOLOGY REPORTS , vol.40, 527-535, 2018

Topcul, Mehmet R. Et Al. "In vitro cytotoxic effect of PARP inhibitor alone and in combination with nab-paclitaxel on triple-negative and luminal A breast cancer cells." ONCOLOGY REPORTS , vol.40, pp.527-535, 2018

Topcul, M. R. Et Al. (2018) . "In vitro cytotoxic effect of PARP inhibitor alone and in combination with nab-paclitaxel on triple-negative and luminal A breast cancer cells." ONCOLOGY REPORTS , vol.40, pp.527-535.

@article{article, author={Mehmet Rıfkı TOPÇUL Et Al. }, title={In vitro cytotoxic effect of PARP inhibitor alone and in combination with nab-paclitaxel on triple-negative and luminal A breast cancer cells}, journal={ONCOLOGY REPORTS}, year=2018, pages={527-535} }